Immunotherapy for Prostate Cancer

Physician-evaluated NK cell immunotherapy for patients diagnosed with Prostate Cancer - at any stage.

Prostate Cancer: Overview

A Prostate cancer diagnosis often leads to immediate decisions around surgery, chemotherapy, and radiation. While these treatments are essential in many cases, some patients seek additional options that support the body beyond conventional approaches.

Natural Killer (NK) Cell Immunotherapy offers a different approach — one focused on strengthening your immune system's natural ability to recognize and respond to abnormal cells.

"Many patients want to know what more they can do. Cellular immunotherapy is one of the most direct answers we have."

Giostar Medical Team

Why early action is Critical

Prostate cancer is common — and often underestimated.

u.s. lifetime risk

1 in 8

men will be diagnosed with prostate cancer during their lifetime.

cancer death ranking

#2

leading cause of cancer death among U.S. men.

Advanced disease may affect

Chronic pain

Urinary dysfunction

Hormonal side effects

Fatigue and reduced mobility

While some forms progress slowly, others become aggressive and resistant to treatment over time. Waiting can allow the disease to advance beyond optimal intervention windows.

Why Consider Cellular Immunotherapy?

Traditional treatments primarily focus on removing or destroying cancer cells. Immunotherapy takes a different path — NK cells are a type of immune cell responsible for identifying and eliminating abnormal cells without prior sensitization.

In prostate cancer, where disease progression can continue even after initial treatments, supporting immune surveillance becomes especially relevant.

Nk cell mechanism

How Natural Killer Cells Target Cancer

Tumor Cell

Cancer cells evade normal immune detection

NK Recognition

NK cells detect "missing self" signals on abnormal cells

Cytotoxic Release

NK cells deploy perforin and granzymes

Cell Elimination

Tumor cell undergoes targeted aproptosis

In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.

NK Cell Therapy is designed to:

Enhance the body's natural immune response

Support identification and elimination of abnormal cells

Complement existing or prior treatments

Provide a systemic, whole-body approach

Are You a Candidate?

NK Cell Immunotherapy may be considered for patients who:

Have been diagnosed with breast cancer (any stage, subject to evaluation)

Are exploring complementary or alternative treatment options

Have not responded as expected to conventional therapies

Are seeking a less invasive, immune-based approach

Want to support their immune system during or after treatment

Every case is individually reviewed by our medical team to determine eligibility and design a personalized protocol.

Not all prostate cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.

A More Comprehensive Approach

At GIOSTAR, treatment goes beyond cellular therapy. Your program may include:

Nutritional support to strengthen immune function

Continuous monitoring through advanced lab testing

Physician-led follow-up and treatment adjustments

Coordinated care for international patients

Clinical process

How the Process Works

Medical Evaluation

Your diagnosis, medical history, and treatment goals are reviewed by our physicians.

Immune Profiling & Blood Collection

A blood sample is collected to isolate immune cells and assess baseline function.

NK Cell Expansion

NK cells are activated and expanded in our specialized laboratory.

Controlled Reinfusion

Expanded NK cells are administered intravenously under clinical protocols.

Monitoring & Follow-Up

Progress is tracked through advanced laboratory testing and physician follow-up.

Next Step: Medical Review

If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.